Telangiectasia macularis eruptiva perstans and multiple myeloma

Journal of the American Academy of Dermatology

Volumn 43, Issue 5 SPEC. SUPPL., 2000, Pages 972-974

  Claude, C ^a,b,c,d,e   Guillemette, Jacqueline ^a,b,c,d,e   Blum, Laurent ^a,b,c,d,e   Turc, Yves ^a,b,c,d,e   Dhôte, Robin ^a,b,c,d,e   Fermand, Jean Paul ^a,b,c,d,e   Aractingi, Selim ^a,b,c,d,e  

^a Centre Hospitalier Laënnec ^*

^b CENTRE HOSPITALIER LAENNEC   (France)

^c Paris Descartes University   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; STEM CELL FACTOR;

AGED; ARTICLE; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MAST CELL; MASTOCYTOSIS; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; TELANGIECTASIA;

EID: 0033767636     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.109254     Document Type: Article

References (17)

1. The skin in mastocytosis
2. Mastocytosis
3. Telangiectasia macularis eruptiva perstans: A case report and review of the literature
4. Mastocytosis and co-existent non-Hogkin's lymphoma and lymphoproliferative disorders
5. Solid and haematological malignancies in 60 patients with systemic mast cell disease
6. Blood findings in generalized mastocytosis: Evidence of frequent simultaneous occurrence of myeloproliferative disorders
7. Increased bone marrow mast cells in preleukemic syndromes, acute leukaemia and lymphoproliferative disorders
8. Pathology of the lymph node and spleen in systemic mast cell disease
9. An osteomedulary pathology in five cases of systemic mastocytosis. Pseudomyelomatous forms with dysglobulinemia and benign polyclonal mastocytosis in the bone marrow. Hamazaki-Wesenberg bodies in mast-cell granulomas
10. Oligoclonal immunoglobulins in mastocytosis
11. Urticaria pigmentosa coexisting with multiple myeloma
12. A case of bone marrow mastocytosis associated with multiple myeloma
13. Identification of a point mutation in the catalytic domain of the proto-oncogen c-kit in peripheral of patients who have mastocytosis with an associated hematologic disorder
14. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in human mast cell neoplasm
15. Activiting and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
16. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells
17. Expression of CD117 antigen (c-kit) on normal and myelomatous plasma cells